Goldman Sachs Group Inc Vincerx Pharma, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Vincerx Pharma, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 631,424 shares of VINC stock, worth $157,856. This represents 0.0% of its overall portfolio holdings.

Number of Shares
631,424
Previous 631,421 -0.0%
Holding current value
$157,856
Previous $511,000 11.15%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$0.51 - $0.84 $1 - $2
3 Added 0.0%
631,424 $454,000
Q2 2024

Aug 13, 2024
SELL
$0.57 - $6.6 $39 - $455
-69 Reduced 0.01%
631,421 $511,000
Q1 2024

May 15, 2024
SELL
$1.07 - $8.06 $1.15 Million - $8.69 Million
-1,078,166 Reduced 63.06%
631,490 $3.2 Million
Q4 2023

Feb 13, 2024
SELL
$0.62 - $1.18 $219,027 - $416,858
-353,270 Reduced 17.12%
1,709,656 $2.02 Million
Q3 2023

May 14, 2024
BUY
$0.66 - $1.38 $233,158 - $487,512
353,270 Added 20.66%
2,062,926 $2.08 Million
Q3 2023

Nov 14, 2023
SELL
$0.66 - $1.38 $15 - $33
-24 Reduced -0.0%
2,062,926 $2.08 Million
Q2 2023

May 14, 2024
SELL
$0.88 - $1.9 $1,708 - $3,689
-1,942 Reduced 0.09%
2,062,950 $2.68 Million
Q2 2023

Aug 14, 2023
SELL
$0.88 - $1.9 $1,708 - $3,689
-1,942 Reduced 0.09%
2,062,950 $2.68 Million
Q1 2023

May 14, 2024
SELL
$0.9 - $1.51 $8,441 - $14,162
-9,379 Reduced 0.45%
2,064,892 $2.15 Million
Q1 2023

May 11, 2023
SELL
$0.9 - $1.51 $8,441 - $14,162
-9,379 Reduced 0.45%
2,064,892 $2.15 Million
Q4 2022

May 14, 2024
BUY
$0.64 - $1.32 $1.32 Million - $2.72 Million
2,060,376 Added 14828.18%
2,074,271 $2.12 Million
Q4 2022

Feb 13, 2023
BUY
$0.64 - $1.32 $1.32 Million - $2.72 Million
2,060,376 Added 14828.18%
2,074,271 $2.12 Million
Q3 2022

May 14, 2024
SELL
$0.0 - $1.72 $0 - $38,237
-22,231 Reduced 61.54%
13,895 $19,000
Q3 2022

Nov 10, 2022
SELL
$0.0 - $1.72 $0 - $38,237
-22,231 Reduced 61.54%
13,895 $0
Q2 2022

May 14, 2024
SELL
$0.0 - $0.0 $0 - $0
-1,673,530 Reduced 97.89%
36,126 $48,000
Q2 2022

Aug 15, 2022
BUY
$0.0 - $0.0 $0 - $0
6,334 Added 21.26%
36,126 $48,000
Q1 2022

May 16, 2022
BUY
$0.0 - $0.0 $0 - $0
29,792 New
29,792 $119,000

Others Institutions Holding VINC

# of Institutions
28
Shares Held
11M
Call Options Held
0
Put Options Held
0
View Full List

About Vincerx Pharma, Inc.

VINC Quotes by TradingView
  • Ticker VINC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,189,800
  • Market Cap $5.3M
  • Description
  • Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...
More about VINC
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email